Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group
Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587)
02/2012
02/23/2012WO2012022265A1 Pyrrolopyrimidine compounds and uses thereof
02/23/2012WO2012022120A1 Dihydropyrazole compounds
02/23/2012WO2012022045A1 Pyrrolopyrimidine compounds and uses thereof
02/23/2012WO2011119894A3 Heterocyclic compounds useful for kinase inhibition
02/23/2012US20120046474 Pyrazole-based cyanine dye containing quaternary ammonium cation
02/23/2012US20120046309 Pyrimidine-2,4,6-triones for use in the treatment of amyotrophic lateral sclerosis
02/23/2012US20120046300 Quinazoline Derivatives as Angiogenesis Inhibitors
02/23/2012US20120046289 Pyridazine Carboxamide Orexin Receptor Antagonists
02/23/2012US20120046275 Cytoskeletal active rho kinase inhibitor compounds, composition and use
02/23/2012US20120046274 6-alkenyl and 6-phenylalkyl substituted 2-quinolinones and 2-quinoxalinones as poly(adp-ribose) polymerase inhibitors
02/23/2012US20120046269 Novel Amino Azaheterocyclic Carboxamides
02/23/2012US20120045784 Biotinidase assay
02/23/2012US20120045454 2,4-pyrimidinediamine compounds and their uses
02/23/2012CA2808543A1 Pyrrolopyrimidine compounds and uses thereof
02/23/2012CA2808540A1 Pyrimidine derivatives as fak inhibitors
02/22/2012EP2420501A1 Novel compound having 3-heteroarylpyrimidin-4-(3h)-one structure and pharmaceutical preparation containing same
02/22/2012EP2420499A1 1H-benzimidazole-4-carboxamides substituted with a quaternary carbon at the 2-position as potent PARP inhibitors
02/22/2012EP2419430A2 Novel compounds of reverse-turn mimetics, method for manufacturing the same and use thereof
02/22/2012EP2419423A1 Fluoro substituted pyrimidine compounds as jak3 inhibitors
02/22/2012EP2419422A1 Imidazolidine-2,4-dione derivatives and use thereof as a medicament
02/22/2012EP2419421A1 Process for preparation of endothelial receptor antagonist (bosentan)
02/22/2012EP2419419A1 4-azetidinyl-1-phenyl-cyclohexane antagonists of ccr2
02/22/2012EP2419418A1 4-azetidinyl-1-heteroatom linked-cyclohexane antagonists of ccr2
02/22/2012EP2419417A1 4-azetidinyl-1-heteroaryl-cyclohexane antagonists of ccr2
02/22/2012EP2419411A1 Quinoxaline derivatives and their use for treating benign and malignant tumour disorders
02/22/2012EP2419405A1 3-(phenoxypyrrolidin-3-yl-methyl)heteroaryl, 3-(phenylpyrrolidin-3-ylmethoxy)heteroaryl, and 3-(heteroarylpyrrolidin-3-ylmethoxy)heteroaryl compounds
02/22/2012EP2419404A1 Anti-viral compounds
02/22/2012EP2310382B1 Amidophenoxyindazoles useful as inhibitors of c-met
02/22/2012EP1963286B1 Pyrazinecarboxamide derivatives and plant disease controlling agents containing the same
02/22/2012EP1644363B1 Triheterocyclic compounds, compositions, and methods for treating cancer
02/22/2012CN102361857A Novel cyclic benzimidazole derivatives useful anti-diabetic agents
02/22/2012CN102358738A 2,4-pyrimidinediamine compounds and uses of treating or preventing autoimmune diseases thereof
02/22/2012CN102070617B 坎地沙坦酯化合物及其新制法 Candesartan cilexetil compounds and freshly France
02/22/2012CN101492416B 影响葡糖激酶的化合物 Effect of compound of glucokinase
02/21/2012US8119805 Substituted disulfonamide compounds
02/21/2012US8119665 Aryl imidazoles and related compounds as C5a receptor modulators
02/21/2012US8119664 Pharmaceutical compositions as inhibitors of dipeptidyl peptidase-IV (DPP-IV)
02/21/2012US8119661 Piperidine derivatives and their use as muscarinic receptor modulators
02/21/2012US8119641 1H-furo[3,2-C]pyrazole compounds useful as kinase inhibitors
02/21/2012US8119631 Inhibitors of interleukin-1β converting enzyme
02/21/2012US8119630 Benzodiazepine derivatives and pharmaceutical compositions containing them
02/21/2012US8119624 Fused phenyl amido heterocyclic compounds
02/21/2012US8119623 Pyrrolidin-2-ones
02/21/2012CA2444031C 3,4-di-substituted cyclobutene-1,2-diones as cxc-chemokine receptor ligands
02/21/2012CA2400141C Pharmaceutical compositions containing azetidine derivatives, novel azetidine derivatives and preparation thereof
02/16/2012WO2012021830A1 4 - aminoquinazolin- 2 - yl - 1 - pyrrazole - 4 - carboxylic acid compounds as prolyl hydroxylase inhibitors
02/16/2012WO2012021591A1 Hepatitis c virus inhibitors
02/16/2012WO2012021144A1 Oligooxopiperazines and methods of making and using them
02/16/2012WO2012020820A1 Heteroaryl-pyrazole derivative
02/16/2012WO2012020787A1 Malignant lymphoma therapeutic agent
02/16/2012WO2012020786A1 Pharmaceutical composition
02/16/2012WO2012020780A1 Heterocyclic compound and use thereof
02/16/2012WO2012020762A1 Hetero ring compound
02/16/2012WO2012020749A1 Triazine derivative and pharmaceutical compound that contains same and exhibits analgesic activity
02/16/2012WO2012020725A1 Heterocyclic derivative having npy y5 receptor antagonism
02/16/2012WO2012020567A1 Acyl piperazine derivatives as ttx-s blockers
02/16/2012WO2012020037A1 Heterocyclic antiviral compounds
02/16/2012WO2012020036A1 Hepatitis c virus inhibitors
02/16/2012WO2012020008A1 Inhibitors of bruton's tyrosine kinase
02/16/2012WO2012019966A1 1,4,5,6-tetrahydro-pyrimidin-2-ylamine compounds
02/16/2012WO2012019427A1 Phthalazinone ketone derivative, preparation method thereof, and pharmaceutical use thereof
02/16/2012WO2012019426A1 Phthalazinone derivative, and preparation method and pharmaceutical use thereof
02/16/2012US20120041200 Process for the preparation of bosentan
02/16/2012US20120041001 Carbonylamino-derivatives as novel inhibitors of histone deacetylase
02/16/2012US20120040997 Vinyl-aryl derivatives for inflammation and immune-related uses
02/16/2012US20120040992 Oligooxopiperazines and methods of making and using them
02/16/2012US20120040986 Omega carboxyaryl substituted diphenyl ureas as raf kinase inhibitors
02/16/2012US20120040985 Triazole and imidazole derivatives for use as tgr5 agonists in the treatment of diabetes and obesity
02/16/2012US20120040980 Quinazolinone compounds
02/16/2012US20120040977 Inhibitors of hcv ns5a
02/16/2012US20120040968 Diamino heterocyclic carboxamide compound
02/16/2012US20120040964 N-substituted piperidines and their use as pharmaceuticals
02/16/2012US20120040955 Fluoro substituted pyrimidine compounds as jak3 inhibitors
02/16/2012US20120040954 Novel anti-inflammatory agents
02/16/2012US20120040952 Azetidines as histamine h3 receptor antagonists
02/16/2012US20120040950 Isoindolinone inhibitors of phosphatidylinositol 3-kinase
02/16/2012US20120040949 Inhibitors of Bruton's Tyrosine Kinase
02/16/2012US20120040948 Aminoindane derivatives, pharmaceutical compositions containing them, and their use in therapy
02/16/2012US20120040947 Tetraline and indane derivatives, pharmaceutical compositions containing them, and their use in therapy
02/16/2012US20120040935 Compositions useful as inhibitors of voltage-gated ion channels
02/16/2012US20120040933 9-(piperazinylalkyl) carbazoles as bax-modulators
02/16/2012US20120040881 Graying-inhibiting washing agent
02/16/2012US20120040837 Insecticidal (1,3,5)-triazinyl phenyl hydrazones
02/16/2012US20120040020 Compounds useful as inhibitors of atr kinase
02/16/2012US20120039913 Selective Histamine H4 Receptor Antagonists for the Treatment of Vestibular Disorders
02/16/2012US20120039848 Hepatitis c virus inhibitors
02/16/2012US20120039847 Hepatitis C Virus Inhibitors
02/16/2012US20120038264 Novel Carbazole Derivatives and Organic Light-Emitting Diode Device Using the Same
02/16/2012CA2808435A1 Heterocyclic compound
02/16/2012CA2808061A1 Hepatitis c virus inhibitors
02/16/2012CA2807947A1 Triazine derivative and pharmaceutical compound that contains same and exhibits analgesic activity
02/16/2012CA2807634A1 Inhibitors of bruton's tyrosine kinase
02/16/2012CA2806547A1 Heterocyclic antiviral compounds
02/16/2012CA2806324A1 Phthalazinone ketone derivative, preparation method thereof, and pharmaceutical use thereof
02/16/2012CA2805867A1 1,4,5,6-tetrahydro-pyrimidin-2-ylamine compounds
02/15/2012EP2418209A1 Aurora kinase modulators and method of use
02/15/2012EP2418207A1 Sulfone compounds which modulate the CB2 receptor
02/15/2012EP2418206A2 Benzodiazepine derivatives useful in the treatment of autoimmune disorders
02/15/2012EP2418205A1 Pyrimidine urea derivatives as kinase inhibitors
02/15/2012EP2417129A1 Triazine-aryl-bis-indoles and process for preparation thereof
1 ... 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 ... 626